The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: A meta-analysis of 5674 patients

Europace

Volumn 15, Issue 7, 2013, Pages 992-1001

  Chen, Shaojie ^a   Ling, Zhiyu ^a   Kiuchi, Márcio Galindo ^d   Yin, Yuehui ^a   Krucoff, Mitchell W ^b,c  

^a THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d Hospital Centrocardio   (Brazil)

Author keywords

Cardiac resynchronization therapy; Heart failure; Outcomes

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CORONARY ARTERY DISSECTION; CORONARY ARTERY PERFORATION; DEVICE INFECTION; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TAMPONADE; HEMATOMA; HEMATOTHORAX; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT SAFETY; PERICARDIAL EFFUSION; PNEUMOTHORAX; PRIORITY JOURNAL; QRS COMPLEX; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CARDIAC RESYNCHRONIZATION THERAPY; HEART FAILURE; OUTCOMES;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; CHI-SQUARE DISTRIBUTION; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PROSTHESIS DESIGN; RECOVERY OF FUNCTION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84879562760     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus419     Document Type: Article

References (40)

1. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-171.
2. Khand A, Gemmel I, Clark A, Cleland JGF. Is the prognosis of heart failure improving? J Am Coll Cardiol 2000;36:2284-6.
3. Cleland JGF, Clark AL. Delivering the cumulative benefits of triple therapy for heart failure. Too many cooks will spoil the broth. J Am Coll Cardiol 2003;42: 1226-33.
4. Al-Majed NS, McAlister FA, Bakal JA, Ezekowitz JA. Meta-analysis: cardiac resyn-chronization therapy for patients with less symptomatic heart failure. Ann Intern Med 2011;154:401-12.
5. McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA 2007;297:2502-14.
6. Rivero-Ayerza M, Theuns DA, Garcia-Garcia HM, Boersma E, Simoons M, Jordaens LJ. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J 2006;27:2682-88.
7. Thijssen J, van Rees JB, Venlet J, Borleffs CJ, Höke U, Putter H et al. The mode of death in implantable cardioverter-defibrillator and cardiac resynchronization therapy with defibrillator patients: results from routine clinical practice. Heart Rhythm 2012;9:1605-12.
8. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA et al. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure of European Society of Cardiology. ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-442.
9. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:746-837.
10. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al., Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
11. The Antiarrhythmics versus Implantable Defbrillators (AVID) Investigators. Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Am Coll Cardiol 1999;34:1552-9.
12. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40.
13. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al., Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
14. Theuns DA, Smith T, Hunink MG, Bardy GH, Jordaens L. Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchroniza-tion therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis. Europace 2010;12:1564-70.
15. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al., American College of Cardiology Foundation; American Heart Association. Guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009;53:e1-90.
16. Lubitz SA, Leong-Sit P, Fine N, Kramer DB, Singh J, Ellinor PT. Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials. Eur J Heart Fail 2010;12:360-6.
17. Wells G, Parkash R, Healey JS, Talajic M, Arnold JM, Sullivan S et al. Cardiac resyn-chronization therapy: a meta-analysis of randomized controlled trials. CMAJ 2011; 183:421-9.
18. Bertoldi EG, Polanczyk CA, Cunha V, Ziegelmann PK, Beck-da-Silva L, Rohde LE. Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure: an updated meta-analysis. Does recent evidence change the standard of care? J Card Fail 2011;17:860-6.
19. Adabag S, Roukoz H, Anand IS, Moss AJ. Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis. J Am Coll Cardiol 2011;58:935-41.
20. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339:b2700.
21. Lozano I, Bocchiardo M, Achtelik M, Gaita F, Trappe HJ, Daoud E et al., VENTAK CHF/CONTAK CD Investigators Study Group. Impact of biventricular pacing on mortality in a randomized crossover study of patients with heart failure and ventricular arrhythmias. Pacing Clin Electrophysiol 2000;23:1711-2.
22. Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intra-ventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003;42:1454-9.
23. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B et al., Multicen-ter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003;289:2685-94.
24. Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA et al. Multicenter InSync ICD II Study Group. Effects of cardiac re-synchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004;110:2864-8.
25. U.S. Food and Drug Administration. Summary of safety and effectiveness data. RHYTHM ICD. 2004. http://www.accessdata.fda.gov/cdrh-docs/pdf3/P030054b. pdf?utm-campaign=Google2&utm-source=fdaSearch&utm-medium=website& utm-term=RHYTHM-ICD&utm-content=1 (28 May 2012, date last accessed).
26. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C, REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52:1834-43.
27. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP et al. MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38.
28. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S et al. Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363:2385-95.
29. Goldenberg I, Moss AJ, Hall WJ, McNitt S, Zareba W, Andrews ML et al. Multi-center Automatic Defibrillator Implantation Trial (MADIT) II Investigators. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 2006;113:2810-7.
30. Sipahi I, Chou JC, Hyden M, Rowland DY, Simon DI, Fang JC. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Am Heart J 2012;163:260-7.
31. Nery PB, Ha AC, Keren A, Birnie DH. Cardiac resynchronization therapy in patients with left ventricular systolic dysfunction and right bundle branch block: a systematic review. Heart Rhythm 2011;8:1083-7.
32. Sipahi I, Carrigan TP, Rowland DY, Stambler BS, Fang JC. Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Arch Intern Med 2011;171:1454-62.
33. Stavrakis S, Lazzara R, Thadani U. The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis. J Cardiovasc Electrophysiol 2012;23: 163-8.
34. Upadhyay GA, Choudhry NK, Auricchio A, Ruskin J, Singh JP. Cardiac resynchro-nization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J Am Coll Cardiol 2008;52:1239-46.
35. Wilton SB, Leung AA, Ghali WA, Faris P, Exner DV. Outcomes of cardiac resyn-chronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm 2011;8:1088-94.
36. Chen S, Yin Y, Krucoff MW. Effect of cardiac resynchronization therapy and implantable cardioverter defibrillator on quality of life in patients with heart failure: a meta-analysis. Europace 2012;14:1602-7.
37. Botto GL, Russo G. Effect of cardiac resynchronization therapy on quality of life: the best gets the least. Europace 2012;14:1537-39.
38. McAlister FA, Tu JV, Newman A, Lee DS, Kimber S, Cujec B et al. How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts. Eur Heart J 2006;27:323-9.
39. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 2006;47:2493-97.
40. Al-Khatib SM, Lucas FL, Jollis JG, Mallenka DJ, Wennberg DE. The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. J Am Coll Cardiol 2005;46:1536-50.